The Latest
The Business of TPM
12.31.20 | 12:06 pm

Here’s an installment from the 20 for 20 Anniversary series about TPM’s business history. It’s by Joe Ragazzo, TPM’s publisher. I’ve told you that all the other pieces I read for first time when they were published. This is the exception. I read a draft and suggested a few changes. But this remains an example of how histories are best told by those who weren’t the primary actors in them. Joe is the right person to tell you this story because of his centrality to the story and deep knowledge about the operation. I hired Joe as my assistant almost eight years ago and he became publisher last year.

Read More

The Business of TPM
12.31.20 | 10:55 am
Nurse Kathe Olmstead prepares a shot as the world's biggest study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway Monday, July 27, 2020, in Binghamton, N.Y. (AP Photo/Hans Pennink) Nurse Kathe Olmstead prepares a shot as the world's biggest study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway Monday, July 27, 2020, in Binghamton, N.Y. (AP Photo/Hans Pennink)
Health Care Workers Refusing Vaccination Prime Badge
12.31.20 | 10:50 am

There’s a fascinating and perhaps ominous article this morning in the LA Times about health care workers who are refusing to take or at least reluctant to take the COVID vaccine. There’s a range of reasons from reasons from things that might strike some of us as irrational to the general hesitancy of not wanting to be first to other things that have some logical basis. One nurse the reporters interviewed is six months pregnant and noted (which I believe is true) that the vaccine hasn’t yet been tested on pregnant women. I don’t know if there’s any clinical reason why this vaccine could operate differently in pregnant women. But I certainly know that many pregnant women and expectant fathers are highly cautious about anything that can disrupt a pregnancy.

I think we fool ourselves, are less than honest with ourselves, if we treat COVID vaccine hesitance or resistance as just a new version of the anti-vaccine activism we’ve seen for the last couple decades. It’s clearly connected to that phenomenon and is fueled by the climate of doubt it has created. But this is a new vaccine and (in the case of the Pfizer and Moderna vaccines) uses a novel vaccine approach. Being wary of going first in such a case is simply not the same as refusing vaccines which have been administered literally billions of times and have track records of short term and long term safety going back decades.

In this photo Dec. 25, 2020 released by Xinhua News Agency, packages of COVID-19 inactivated vaccine products are seen at a production plant of the Beijing Biological Products Institute Co., Ltd, a unit of state-owned Sinopharm in Beijing. The Chinese drugmaker said Wednesday, Dec. 30, 2020 its coronavirus vaccine was found to be 79.3% effective at preventing infection in preliminary data from the final round of testing, moving Beijing closer to possibly being able to fulfill its pledge to supply other developing countries.(Zhang Yuwei/Xinhua via AP) In this photo Dec. 25, 2020 released by Xinhua News Agency, packages of COVID-19 inactivated vaccine products are seen at a production plant of the Beijing Biological Products Institute Co., Ltd, a unit of state-owned Sinopharm in Beijing. The Chinese drugmaker said Wednesday, Dec. 30, 2020 its coronavirus vaccine was found to be 79.3% effective at preventing infection in preliminary data from the final round of testing, moving Beijing closer to possibly being able to fulfill its pledge to supply other developing countries.(Zhang Yuwei/Xinhua via AP)
Los Angeles, California—Oct. 30, 2020—Gov. Gavin Newsom talks to the media after visiting Dodger Stadium on Oct. 30, 2020. (Carolyn Cole/ Los Angeles Times) Los Angeles, California—Oct. 30, 2020—Gov. Gavin Newsom talks to the media after visiting Dodger Stadium on Oct. 30, 2020. (Carolyn Cole/ Los Angeles Times)